{
  "pmid": "40452604",
  "title": "The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis.",
  "abstract": "",
  "pub_date": "2025-06-02",
  "publication_types": [
    "Letter"
  ],
  "affiliations": [
    "Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.",
    "Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.",
    "Department of Dermatology, Nippon Medical School, Tokyo, Japan.",
    "Fujimoto Dermatology Clinic, Funabashi, Japan.",
    "Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan."
  ],
  "url": "https://pubmed.ncbi.nlm.nih.gov/40452604/",
  "snapshot_id": "2026-02-12T15-09-21Z",
  "ingested_at": "2026-02-12T15:09:25.497525+00:00"
}